Ray McDermott

Also affiliated with University of Alberta, Tallaght University Hospital, Cancer Trials Ireland, St. Vincent's University Hospital, Dublin Dental University Hospital, Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2021)10.1056/nejmoa2034442

N/A

7.0DataRank · unranked

1043 citations

J. Alfred Witjes, Jürgen E. Gschwend, Michael Schenker, Begoña P. Valderrama, Yoshihiko Tomita +24 more

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The Oncologist(2022)10.1093/oncolo/oyac080

N/A

1.7DataRank · unranked

49 citations

Christina S. Baik, Jessica R. Bauman, Jill Gilbert, Marcia S. Brose, Juneko E. Grilley‐Olson +13 more

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Cancer(2023)10.1002/cncr.35036

N/A

0.937DataRank · unranked

25 citations

Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

Gut(2025)10.1136/gutjnl-2024-334026

N/A

0.567DataRank · unranked

18 citations

Sepideh Babaei, Rajiv Trehan, Christoph Hoffman, Noémi Kedei, Benjamin Ruf +33 more